Cargando…

Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans

Background: There is an association between insulin resistance (IR) and hyperuricemia but the direction of causalityand mechanisms are unclear. In obesity and lipodystrophy, IR is “selective”, with lack of insulin signalingcausing hyperglycemia, but enhanced insulin signaling causing dyslipidemia an...

Descripción completa

Detalles Bibliográficos
Autores principales: Haykal, Rasha, Kinzer, Alexandra, Abel, Brent, Startzell, Megan S, Cochran, Elaine, Brown, Rebecca J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089614/
http://dx.doi.org/10.1210/jendso/bvab048.839
_version_ 1783687081046835200
author Haykal, Rasha
Kinzer, Alexandra
Abel, Brent
Startzell, Megan S
Cochran, Elaine
Brown, Rebecca J
author_facet Haykal, Rasha
Kinzer, Alexandra
Abel, Brent
Startzell, Megan S
Cochran, Elaine
Brown, Rebecca J
author_sort Haykal, Rasha
collection PubMed
description Background: There is an association between insulin resistance (IR) and hyperuricemia but the direction of causalityand mechanisms are unclear. In obesity and lipodystrophy, IR is “selective”, with lack of insulin signalingcausing hyperglycemia, but enhanced insulin signaling causing dyslipidemia and possibly hyperuricemia. Rare human conditions exist in which there is extreme, non-selective, IR impairing all insulin signalingpathways (e.g. mutations of the insulin receptor, INSR). We hypothesized that hyperinsulinemia withenhanced signaling through the insulin receptor causes hyperuricemia in selective IR, whereas lack ofinsulin signaling through its receptor despite hyperinsulinemia results in normal uricemia in non-selective IR. Method: Cross-sectional retrospective analysis comparing fasting insulin and serum uric acid in patients withsevere IR that was either selective (due to lipodystrophy) or non-selective (due to INSR mutation orautoantibody to the insulin receptor). Visits were chosen based on availability of serum uric acid andinsulin. If multiple visits were available, the visit with the highest insulin value was chosen. Results: We analyzed data of 68 patients with selective IR and 14 patients with non-selective IR. Fasting seruminsulin median [interquartile range] was 23.4 [14, 53] mcU/mL in selective IR vs 215 [73.7, 604] in non-selective IR, p <0.0001. Serum uric acid was 4.8 [2, 6] mg/dL in selective IR vs 3.5 [2, 4] in non-selectiveIR, p=0.0003. Conclusion: Patients with selective IR due to lipodystrophy had elevated serum uric acid, consistent with thehyperuricemia seen in selective IR caused by obesity. By contrast, patients with non-selective IR hadlower serum uric acid despite more severe IR as evidenced by almost 10-fold higher fasting insulin. These observations are consistent with a model in which enhanced insulin signaling through its receptorleads to hyperuricemia in post-receptor IR. Further studies are needed to understand the mechanism bywhich insulin leads to hyperuricemia.
format Online
Article
Text
id pubmed-8089614
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80896142021-05-06 Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans Haykal, Rasha Kinzer, Alexandra Abel, Brent Startzell, Megan S Cochran, Elaine Brown, Rebecca J J Endocr Soc Diabetes Mellitus and Glucose Metabolism Background: There is an association between insulin resistance (IR) and hyperuricemia but the direction of causalityand mechanisms are unclear. In obesity and lipodystrophy, IR is “selective”, with lack of insulin signalingcausing hyperglycemia, but enhanced insulin signaling causing dyslipidemia and possibly hyperuricemia. Rare human conditions exist in which there is extreme, non-selective, IR impairing all insulin signalingpathways (e.g. mutations of the insulin receptor, INSR). We hypothesized that hyperinsulinemia withenhanced signaling through the insulin receptor causes hyperuricemia in selective IR, whereas lack ofinsulin signaling through its receptor despite hyperinsulinemia results in normal uricemia in non-selective IR. Method: Cross-sectional retrospective analysis comparing fasting insulin and serum uric acid in patients withsevere IR that was either selective (due to lipodystrophy) or non-selective (due to INSR mutation orautoantibody to the insulin receptor). Visits were chosen based on availability of serum uric acid andinsulin. If multiple visits were available, the visit with the highest insulin value was chosen. Results: We analyzed data of 68 patients with selective IR and 14 patients with non-selective IR. Fasting seruminsulin median [interquartile range] was 23.4 [14, 53] mcU/mL in selective IR vs 215 [73.7, 604] in non-selective IR, p <0.0001. Serum uric acid was 4.8 [2, 6] mg/dL in selective IR vs 3.5 [2, 4] in non-selectiveIR, p=0.0003. Conclusion: Patients with selective IR due to lipodystrophy had elevated serum uric acid, consistent with thehyperuricemia seen in selective IR caused by obesity. By contrast, patients with non-selective IR hadlower serum uric acid despite more severe IR as evidenced by almost 10-fold higher fasting insulin. These observations are consistent with a model in which enhanced insulin signaling through its receptorleads to hyperuricemia in post-receptor IR. Further studies are needed to understand the mechanism bywhich insulin leads to hyperuricemia. Oxford University Press 2021-05-03 /pmc/articles/PMC8089614/ http://dx.doi.org/10.1210/jendso/bvab048.839 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Diabetes Mellitus and Glucose Metabolism
Haykal, Rasha
Kinzer, Alexandra
Abel, Brent
Startzell, Megan S
Cochran, Elaine
Brown, Rebecca J
Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title_full Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title_fullStr Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title_full_unstemmed Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title_short Enhanced Insulin Signaling Through Its Receptor Is Needed for the Development of Hyperuricemia in Humans
title_sort enhanced insulin signaling through its receptor is needed for the development of hyperuricemia in humans
topic Diabetes Mellitus and Glucose Metabolism
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089614/
http://dx.doi.org/10.1210/jendso/bvab048.839
work_keys_str_mv AT haykalrasha enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans
AT kinzeralexandra enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans
AT abelbrent enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans
AT startzellmegans enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans
AT cochranelaine enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans
AT brownrebeccaj enhancedinsulinsignalingthroughitsreceptorisneededforthedevelopmentofhyperuricemiainhumans